AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Resmed DRC

40.170

+0.4501.13%

Volume:690.46K

Turnover:27.66M

Market Cap:58.80B

PE:2.94

High:40.170

Open:39.850

Low:39.850

Close:39.720

Loading ...

Overview Company News Filings

ResMed Inc. Stock Falls Friday, Underperforms Market

ResMed CFO Sells Shares

MT Newswires Live

Broker reveals which ASX stocks are rate-cut winners

Should you buy the dip in the ResMed share price?

ResMed Inc. Stock Falls Tuesday, Underperforms Market

BUZZ-Australia's ResMed slips after rival Apnimed posts positive clinical trial results

Down 5%: What's going on with the ResMed share price?

How to earn $1,000 a month in passive income from ASX shares

3 ASX shares for beginners to buy with $500

ResMed Inc. Stock Rises Friday, Outperforms Market

ResMed Inc. Stock Rises Monday, Still Underperforms Market

If I were building a portfolio from scratch, I'd buy these 3 ASX 200 shares today

3 ASX 200 shares for smart investors to buy

The best ASX 200 retirement shares to buy in May

ResMed Inc. Stock Rises Wednesday, Outperforms Market

Top brokers name 3 ASX shares to buy next week

Is It Smart To Buy ResMed Inc. (NYSE:RMD) Before It Goes Ex-Dividend?

Simply Wall St.

ResMed Inc. Stock Rises Friday, Still Underperforms Market

ResMed Acquires US-Based Diagnostic Testing Services Provider for Undisclosed Sum

MT Newswires Live

ResMed Buys VirtuOx for Undisclosed sum

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RMD.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RMD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RMD.AU\",,,,,undefined,":{"symbol":"RMD.AU","market":"AU","secType":"STK","nameCN":"Resmed DRC","latestPrice":40.17,"timestamp":1753164720000,"preClose":39.72,"halted":0,"volume":690460,"delay":0,"nameEN":"Resmed DRC","floatShares":145464448,"shares":1463854030,"eps":13.680912450845058,"marketStatus":"Closed","change":0.45,"latestTime":"07-22 16:12:00 AEST","open":39.85,"high":40.17,"low":39.85,"amount":27659108,"amplitude":0.008056,"askPrice":40.19,"askSize":3375,"bidPrice":40.1,"bidSize":70,"shortable":3,"etf":0,"ttmEps":13.680912450845058,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1753228800000},"marketStatusCode":5,"adr":0,"adrRate":1,"exchange":"ASX","adjPreClose":39.72,"dividendRate":0.008215,"openAndCloseTimeList":[[1753142400000,1753164000000]],"volumeRatio":1.160803,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RMD.AU\",,,,,undefined,":{"symbol":"RMD.AU","floatShares":145464448,"roa":"14.01%","roe":"25.81%","lyrEps":0.959683,"volumeRatio":1.160803,"shares":1463854030,"dividePrice":0.33,"high":40.17,"amplitude":0.008056,"preClose":39.72,"low":39.85,"week52Low":29.85,"pbRate":"6.90","psRate":"7.63","week52High":40.571,"institutionHeld":0,"latestPrice":40.17,"committee":-0.959361,"eps":13.680912450845058,"divideRate":0.008215,"volume":690460,"delay":0,"ttmEps":13.680912450845058,"open":39.85,"prevYearClose":36.609,"prevWeekClose":39.81,"prevMonthClose":39.35,"prevQuarterClose":39.35,"fiveDayClose":38.75,"twentyDayClose":39.15,"sixtyDayClose":36.849},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RMD.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2537152093","title":"ResMed Inc. Stock Falls Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2537152093","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537152093?lang=en_us&edition=fundamental","pubTime":"2025-05-24 04:54","pubTimestamp":1748033640,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  shed 1.08% to $242.84 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.67% to 5,802.82 and Dow Jones Industrial Average  falling 0.61% to 41,603.07.This was the stock's fourth consecutive day of losses.ResMed Inc. closed 7.68% short of its 52-week high of $263.05, which the company achieved on January 30th.Trading volume  remained 555,172 below its 50-day average volume of 1.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 23, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD","RMD.AU"],"gpt_icon":0},{"id":"2537397395","title":"ResMed CFO Sells Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2537397395","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537397395?lang=en_us&edition=fundamental","pubTime":"2025-05-23 07:18","pubTimestamp":1747955900,"startTime":"0","endTime":"0","summary":"ResMed (ASX:RMD) Chief Financial Officer Brett Sandercock sold 3,644 shares on the New York Stock Exchange for about $891,286 in total, according to a Friday filing with the Australian bourse.Following the sale of shares, Sandercock owns about 146.6 million shares in the company, per the filing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4567","RMD","LU0170899867.USD","XJO.AU","BK4588","LU2177674079.SGD","XAO.AU","XKO.AU","BK4082","BK4548","BK4504","RMD.AU","BK7501","BK4585","LU2008162690.USD","BK7007"],"gpt_icon":0},{"id":"2537903462","title":"Broker reveals which ASX stocks are rate-cut winners","url":"https://stock-news.laohu8.com/highlight/detail?id=2537903462","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537903462?lang=en_us&edition=fundamental","pubTime":"2025-05-23 06:30","pubTimestamp":1747953000,"startTime":"0","endTime":"0","summary":"The Reserve Bank of Australia delivered its second 0.25% interest rate cut for 2025 this week. Macquarie says there are more interest rate cuts to come and is tipping three further reductions in July, August, and November.  The broker has released a note revealing its favoured 'rate-cut basket' of ASX stocks.  These are the ASX stocks it expects to outperform amid continual interest rate cuts over the next year.  So, which ones are they?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/05/23/broker-reveals-which-asx-stocks-are-rate-cut-winners/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["HVN.AU","WOW.AU","BK7128","XRO.AU","BK7007","BK7155","JBH.AU","BK7511","BK7038","BK7040","BK7002","BK7016","BK7001","GMG.AU","BK7046","MP1.AU","NXT.AU","BK7153","NWS.AU","BK7503","LOV.AU","BK7099","MGR.AU","BK7501","BK7043","BK7082","BK7041","COL.AU","BK7087","BK7510","MQG.AU","RMD.AU","SEK.AU"],"gpt_icon":0},{"id":"2537862227","title":"Should you buy the dip in the ResMed share price?","url":"https://stock-news.laohu8.com/highlight/detail?id=2537862227","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537862227?lang=en_us&edition=fundamental","pubTime":"2025-05-21 07:41","pubTimestamp":1747784464,"startTime":"0","endTime":"0","summary":"TheResMed Inc share price was under pressure on Tuesday and dropped into the red. Investors were selling the sleep disorder treatment company's shares in response to the release oftrial resultsfrom a potential future competitor in the obstructive sleep apnoea  treatment space. Those results revealed that US-based biotech companyApnimed's lead candidate, AD109, met its primary endpoint in its Phase 3 SynAIRgy clinical trial. AD109 is a once-daily oral pill designed to treat OSA by targeting the neuromuscular root cause of the condition. Should you buy the dip in the ResMed share price?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/05/21/should-you-buy-the-dip-in-the-resmed-share-price/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["RMD","BK4567","LU2008162690.USD","BK4548","BK4082","BK4504","BK7007","BK7501","LU2177674079.SGD","LU0170899867.USD","BK4588","BK4585","RMD.AU"],"gpt_icon":0},{"id":"2537158625","title":"ResMed Inc. Stock Falls Tuesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2537158625","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537158625?lang=en_us&edition=fundamental","pubTime":"2025-05-21 04:56","pubTimestamp":1747774560,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  slid 2.06% to $248.14 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.39% to 5,940.46 and Dow Jones Industrial Average  falling 0.27% to 42,677.24.The stock's fall snapped a three-day winning streak.ResMed Inc. closed 5.67% below its 52-week high of $263.05, which the company achieved on January 30th.Trading volume  eclipsed its 50-day average volume of 1.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 20, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD.AU","RMD"],"gpt_icon":0},{"id":"2536647376","title":"BUZZ-Australia's ResMed slips after rival Apnimed posts positive clinical trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2536647376","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536647376?lang=en_us&edition=fundamental","pubTime":"2025-05-20 13:45","pubTimestamp":1747719911,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's ResMed slips after rival Apnimed posts positive clinical trial results** ASX-listed shares of medical device-maker ResMed RMD.AX fall as much as 7.3% to A$36.02, their lowest level since April 24** Stock of co, which is involved in treating sleep apnea, COPD and other chronic diseases, marks biggest intraday pct loss since March 12 ** RMD is the top pct loser on the ASX 200 benchmark ** Rival Apnimed, which is unlisted, announced positive topline results in first phase 3 clinical trial of AD109, an oral pill for obstructive sleep apnea  ** Stock up 0.6% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nL4N3RS0FX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","BK4548","BK4585","BK4082","LU2008162690.USD","LU2177674079.SGD","BK4567","RMD","RMD.AU","LU0170899867.USD","BK4588","BK4504","BK7501"],"gpt_icon":0},{"id":"2536669736","title":"Down 5%: What's going on with the ResMed share price?","url":"https://stock-news.laohu8.com/highlight/detail?id=2536669736","media":"MotleyFool","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536669736?lang=en_us&edition=fundamental","pubTime":"2025-05-20 11:53","pubTimestamp":1747713225,"startTime":"0","endTime":"0","summary":"The ResMed Inc  share price is under pressure on Tuesday. At the time of writing, the sleep disorder treatment company's shares are down 5% to $36.90. Why is the ResMed share price tumbling?While ResMed is widely regarded as the global leader in sleep apnoea therapy — with its CPAP devices and cloud-connected solutions used by millions — the success of a non-device-based treatment could introduce a new dynamic to the market. However, it is worth remembering that ResMed remains deeply entrenched in the sleep apnoea market — both in terms of scale and clinical infrastructure. The company continues to benefit from strong global brand and clinician trust, recurring revenue through device and SaaS models, a growing pipeline of cloud-connected solutions and data tools, and an unmatched distribution network. It is also important to note that AD109 is still in the trial phase, with no regulatory approval yet in place. So, today's decline might prove to be a bit of an overreaction, but time wil","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/05/20/down-5-whats-going-on-with-the-resmed-share-price/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7501","BK4504","BK4567","BK4585","BK4548","LU0170899867.USD","LU2008162690.USD","BK4082","BK7007","LU2177674079.SGD","RMD.AU","BK4588","RMD"],"gpt_icon":0},{"id":"2536651901","title":"How to earn $1,000 a month in passive income from ASX shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2536651901","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536651901?lang=en_us&edition=fundamental","pubTime":"2025-05-20 07:46","pubTimestamp":1747698373,"startTime":"0","endTime":"0","summary":"Time and consistency. Reinvest your dividends in the early years. Keep adding to your portfolio monthly, even in down markets. Don't get distracted by noise or short-term corrections. Let compounding do the heavy lifting. Foolish takeaway Earning $1,000 a month in passive income from ASX shares doesn't require luck or perfect timing — just a simple, disciplined strategy built around quality, consistency, and time in the market. Focus on growing your capital first. Reinvest every cent. And when the time is right, switch gears into income mode and enjoy the cash flow you've spent years building toward.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/05/20/how-to-earn-1000-a-month-in-passive-income-from-asx-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["GMG.AU","BK7007","TLS.AU","BK7501","BK7155","BK7511","BK7021","BK7040","BK7510","BK7042","COL.AU","VHY.AU","RMD.AU","BK7099","BK7082","AX1.AU"],"gpt_icon":0},{"id":"2536534846","title":"3 ASX shares for beginners to buy with $500","url":"https://stock-news.laohu8.com/highlight/detail?id=2536534846","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536534846?lang=en_us&edition=fundamental","pubTime":"2025-05-18 05:09","pubTimestamp":1747516140,"startTime":"0","endTime":"0","summary":"Starting your investing journey can feel overwhelming — but it doesn't have to be. You don't need thousands of dollars or a background in finance to begin building wealth. In fact, with just $500, you","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/05/18/3-asx-shares-for-beginners-to-buy-with-500/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7128","TLX.AU","BK7067","BK7007","LOV.AU","RMD.AU","BK7501"],"gpt_icon":0},{"id":"2536900323","title":"ResMed Inc. Stock Rises Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2536900323","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536900323?lang=en_us&edition=fundamental","pubTime":"2025-05-17 04:54","pubTimestamp":1747428840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  advanced 1.25% to $251.69 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.70% to 5,958.38 and the Dow Jones Industrial Average  rising 0.78% to 42,654.74.This was the stock's second consecutive day of gains.ResMed Inc. closed 4.32% short of its 52-week high of $263.05, which the company achieved on January 30th.Trading volume  remained 309,265 below its 50-day average volume of 1.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 16, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD.AU","RMD"],"gpt_icon":0},{"id":"2535678222","title":"ResMed Inc. Stock Rises Monday, Still Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2535678222","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535678222?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:54","pubTimestamp":1747083240,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  rallied 1.07% to $247.66 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 3.26% to 5,844.19 and the Dow Jones Industrial Average  rising 2.81% to 42,410.10.This was the stock's second consecutive day of gains.ResMed Inc. closed 5.85% below its 52-week high of $263.05, which the company reached on January 30th.Trading volume  remained 238,790 below its 50-day average volume of 1.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 12, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD.AU","RMD"],"gpt_icon":0},{"id":"2534237764","title":"If I were building a portfolio from scratch, I'd buy these 3 ASX 200 shares today","url":"https://stock-news.laohu8.com/highlight/detail?id=2534237764","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534237764?lang=en_us&edition=fundamental","pubTime":"2025-05-12 05:17","pubTimestamp":1746998273,"startTime":"0","endTime":"0","summary":"Starting fresh with a clean slate might just be the best position an investor can be in. No baggage, no bias — just a long time horizon and the freedom to choose businesses you truly believe in. If I ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/05/12/if-i-were-building-a-portfolio-from-scratch-id-buy-these-3-asx-200-shares-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7501","BK7067","RMD.AU","WTC.AU","BK7511","BK7016","BK7508","BK7007","CSL.AU","BK7503"],"gpt_icon":0},{"id":"2534049657","title":"3 ASX 200 shares for smart investors to buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2534049657","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534049657?lang=en_us&edition=fundamental","pubTime":"2025-05-10 06:36","pubTimestamp":1746830160,"startTime":"0","endTime":"0","summary":"Smart investors know that long-term wealth isn't built on hype — it is built by owning quality businesses with real earnings power, global opportunity, and the ability to compound growth over time. Ri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/05/10/3-asx-200-shares-for-smart-investors-to-buy/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7067","BK7501","BK7007","BK7044","JHX.AU","TLX.AU","RMD.AU"],"gpt_icon":0},{"id":"2534169488","title":"The best ASX 200 retirement shares to buy in May","url":"https://stock-news.laohu8.com/highlight/detail?id=2534169488","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534169488?lang=en_us&edition=fundamental","pubTime":"2025-05-09 02:10","pubTimestamp":1746727800,"startTime":"0","endTime":"0","summary":"When building a retirement portfolio, you want to have the best ASX shares you can find in there. Anything less, simply won't do and could have a serious impact on your lifestyle in the future. But which ASX retirement shares could be best buys?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/05/09/the-best-asx-200-retirement-shares-to-buy-in-may/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7145","RMD.AU","BK7007","CWP.AU","BK7501"],"gpt_icon":0},{"id":"2533962531","title":"ResMed Inc. Stock Rises Wednesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2533962531","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533962531?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:57","pubTimestamp":1746651420,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  rallied 1.14% to $244.70 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.43% to 5,631.28 and the Dow Jones Industrial Average  rising 0.70% to 41,113.97.This was the stock's fourth consecutive day of gains.ResMed Inc. closed 6.98% below its 52-week high of $263.05, which the company achieved on January 30th.Trading volume  remained 373,977 below its 50-day average volume of 1.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 7, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD.AU","RMD"],"gpt_icon":0},{"id":"2533034141","title":"Top brokers name 3 ASX shares to buy next week","url":"https://stock-news.laohu8.com/highlight/detail?id=2533034141","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533034141?lang=en_us&edition=fundamental","pubTime":"2025-05-04 06:01","pubTimestamp":1746309660,"startTime":"0","endTime":"0","summary":"It was another busy week for Australia's top brokers. This has led to the release of a number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Her","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/05/04/top-brokers-name-3-asx-shares-to-buy-next-week-4-may-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7007","IE0034235188.USD","IE00BSNM7G36.USD","LU2237443895.HKD","LU0742534661.SGD","LU2237443382.USD","LU2471134879.HKD","LU0096364046.USD","BK7506","LU1868837300.USD","LU2750360641.GBP","LU1791807156.HKD","IE0004086264.USD","IE00B19Z3B42.SGD","BK4127","LU0251142724.SGD","LU2237443549.SGD","LU1868836914.USD","LU1868836757.USD","BK4504","IE00BFXG1179.USD","BK4516","BK4588","BK4533","LU1668664300.SGD","LU2237438978.USD","RMD.AU","IE00B19Z3581.USD","LU0251131958.USD","LU2750360997.AUD","LU2471134523.USD","LU2237443622.USD","BK4585","LU2471134796.USD","BK7040","BK4550","WOW.AU","NST.AU","IE0002270589.USD","LU1868837136.USD","LU2237443978.SGD","LU2471134952.CNY","BK4552","LU0061475181.USD","LU2237443465.HKD","LU0048573561.USD","BK7501","BK7511","BK7104","IE0004091025.USD"],"gpt_icon":0},{"id":"2532371473","title":"Is It Smart To Buy ResMed Inc. (NYSE:RMD) Before It Goes Ex-Dividend?","url":"https://stock-news.laohu8.com/highlight/detail?id=2532371473","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532371473?lang=en_us&edition=fundamental","pubTime":"2025-05-03 21:44","pubTimestamp":1746279877,"startTime":"0","endTime":"0","summary":"Readers hoping to buy ResMed Inc.  for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is usually set to be one business day before the record date, which is the cut-off date on which you must be present on the company's books as a shareholder in order to receive the dividend. The ex-dividend date is important because any transaction on a stock needs to have been settled before the record date in order to be eligible for a dividend. Accordingly, ResMed investors that purchase the stock on or after the 8th of May will not receive the dividend, which will be paid on the 12th of June.The company's next dividend payment will be US$0.53 per share, and in the last 12 months, the company paid a total of US$2.12 per share. Based on the last year's worth of payments, ResMed has a trailing yield of 0.9% on the current stock price of US$239.95. We love seeing companies pay a dividend, but it's also important to be sure that layin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/smart-buy-resmed-inc-nyse-134437664.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RMD.AU","BK4588","BK4548","LU2008162690.USD","BK4567","RMD","BK4504","BK4585","BK4082","LU2177674079.SGD","NYSE","LU0170899867.USD"],"gpt_icon":0},{"id":"2532387255","title":"ResMed Inc. Stock Rises Friday, Still Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2532387255","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532387255?lang=en_us&edition=fundamental","pubTime":"2025-05-03 04:54","pubTimestamp":1746219240,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  rose 1.46% to $239.95 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 1.47% to 5,686.67 and the Dow Jones Industrial Average  rising 1.39% to 41,317.43.The stock's rise snapped a two-day losing streak.ResMed Inc. closed 8.78% short of its 52-week high of $263.05, which the company reached on January 30th.Trading volume  remained 524,240 below its 50-day average volume of 1.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 2, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD","RMD.AU"],"gpt_icon":0},{"id":"2532834744","title":"ResMed Acquires US-Based Diagnostic Testing Services Provider for Undisclosed Sum","url":"https://stock-news.laohu8.com/highlight/detail?id=2532834744","media":"MT Newswires Live","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532834744?lang=en_us&edition=fundamental","pubTime":"2025-05-02 06:50","pubTimestamp":1746139805,"startTime":"0","endTime":"0","summary":"ResMed (ASX:RMD) acquired VirtuOx, a US-based diagnostic testing provider for sleep, respiratory, and cardiac conditions, according to a Thursday statement by the company.Under the deal, VirtuOx will ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","LU0170899867.USD","RMD","BK4567","BK4504","LU2008162690.USD","BK4588","BK4585","BK7007","RMD.AU","LU2177674079.SGD","BK4548","BK4082"],"gpt_icon":0},{"id":"2532000159","title":"ResMed Buys VirtuOx for Undisclosed sum","url":"https://stock-news.laohu8.com/highlight/detail?id=2532000159","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532000159?lang=en_us&edition=fundamental","pubTime":"2025-05-01 22:50","pubTimestamp":1746111036,"startTime":"0","endTime":"0","summary":"ResMed  said Thursday it acquired VirtuOx, an independent diagnostic testing facility for sleep, respiratory and cardiac conditions.After the deal, VirtuOx will operate as a fully owned unit of ResMed. ResMed said the financial terms were not disclosed as the transaction is immaterial to its financial results.Price: 238.35, Change: +1.76, Percent Change: +0.74","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RMD.AU","BK4548","BK4588","BK4585","RMD","BK4567","BK4504","LU0170899867.USD","BK4082","BK7501","BK7007","LU2177674079.SGD","LU2008162690.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RMD.AU\",params:#limit:5,,,undefined,":[{"date":"2025-05-07","symbol":"RMD.AU","amount":0.053,"announcedDate":"2025-04-24","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-05-08","defaultRemindTime":1746576000000,"name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-12","payableDate":"2025-05-08","currency":"USD","dateTimestamp":1746540000000,"payDate":"2025-06-12"},{"date":"2025-02-12","symbol":"RMD.AU","amount":0.053,"announcedDate":"2025-01-31","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-02-13","name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-20","payableDate":"2025-02-13","currency":"USD","dateTimestamp":1739278800000,"payDate":"2025-03-20"},{"date":"2024-11-06","symbol":"RMD.AU","amount":0.053,"announcedDate":"2024-10-25","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-11-07","name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-12","payableDate":"2024-11-07","currency":"USD","dateTimestamp":1730811600000,"payDate":"2024-12-12"},{"date":"2024-08-14","symbol":"RMD.AU","amount":0.053,"announcedDate":"2024-08-02","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-08-15","defaultRemindTime":1723593600000,"name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-19","payableDate":"2024-08-15","currency":"USD","dateTimestamp":1723557600000,"payDate":"2024-09-19"},{"date":"2024-05-08","symbol":"RMD.AU","amount":0.048,"announcedDate":"2024-04-26","type":"dividend","market":"AU","newRecordDate":"2024-05-09","defaultRemindTime":1715126400000,"name":"Resmed DRC","recordDate":"2024-06-13","payableDate":"2024-05-09","currency":"USD","dateTimestamp":1715090400000,"payDate":"2024-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RMD.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-08-19","recordDate":"2020-08-20","paymentDate":"2020-09-24","value":0.039,"currency":"USD"},{"executeDate":"2020-11-11","recordDate":"2020-11-12","paymentDate":"2020-12-17","value":0.039,"currency":"USD"},{"executeDate":"2021-02-10","recordDate":"2021-02-11","paymentDate":"2021-03-18","value":0.039,"currency":"USD"},{"executeDate":"2021-05-12","recordDate":"2021-05-13","paymentDate":"2021-06-17","value":0.039,"currency":"USD"},{"executeDate":"2021-08-18","recordDate":"2021-08-19","paymentDate":"2021-09-23","value":0.042,"currency":"USD"}]}}